Golden State Wealth Management LLC Acquires 3,062 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Golden State Wealth Management LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 178.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,776 shares of the healthcare conglomerate's stock after buying an additional 3,062 shares during the period. Golden State Wealth Management LLC's holdings in UnitedHealth Group were worth $2,503,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. Aurora Private Wealth Inc. acquired a new stake in shares of UnitedHealth Group in the first quarter worth $8,818,000. MOKAN Wealth Management Inc. raised its position in UnitedHealth Group by 17.3% in the first quarter. MOKAN Wealth Management Inc. now owns 5,361 shares of the healthcare conglomerate's stock valued at $2,807,000 after purchasing an additional 790 shares during the period. waypoint wealth counsel boosted its position in shares of UnitedHealth Group by 21.4% in the first quarter. waypoint wealth counsel now owns 1,082 shares of the healthcare conglomerate's stock worth $567,000 after buying an additional 191 shares during the period. Adams Diversified Equity Fund Inc. lifted its position in UnitedHealth Group by 56.8% during the 1st quarter. Adams Diversified Equity Fund Inc. now owns 50,800 shares of the healthcare conglomerate's stock worth $26,606,000 after acquiring an additional 18,400 shares in the last quarter. Finally, Mattern Capital Management LLC grew its position in UnitedHealth Group by 2.5% in the first quarter. Mattern Capital Management LLC now owns 19,184 shares of the healthcare conglomerate's stock valued at $10,048,000 after acquiring an additional 471 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH traded up $0.41 on Thursday, hitting $302.43. The stock had a trading volume of 6,497,799 shares, compared to its average volume of 7,416,648. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company's 50-day moving average is $342.22 and its two-hundred day moving average is $458.07. The stock has a market cap of $274.35 billion, a price-to-earnings ratio of 12.66, a P/E/G ratio of 1.43 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the previous year, the company posted $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. UnitedHealth Group's dividend payout ratio is 37.02%.

Insiders Place Their Bets

In other news, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on UNH shares. Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a report on Wednesday, June 11th. Deutsche Bank Aktiengesellschaft reduced their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. HSBC reaffirmed a "reduce" rating and issued a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.